Found: 83
Select item for more details and to access through your institution.
Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1055, doi. 10.1093/oncolo/oyad181
- By:
- Publication type:
- Article
Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6768, doi. 10.1002/cam4.5465
- By:
- Publication type:
- Article
Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER–Medicare Database Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133206
- By:
- Publication type:
- Article
A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2639, doi. 10.3390/cancers14112639
- By:
- Publication type:
- Article
Advances in Treatment of Recurrent Small Cell Lung Cancer (SCLC): Insights for Optimizing Patient Outcomes from an Expert Roundtable Discussion.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 11, p. 5431, doi. 10.1007/s12325-021-01909-1
- By:
- Publication type:
- Article
Physician Communication and Patient Understanding of Molecular Testing Terminology.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 934, doi. 10.1002/onco.13930
- By:
- Publication type:
- Article
Discovery of Small Molecule Bak Activator for Lung Cancer Therapy.
- Published in:
- Theranostics, 2021, v. 11, n. 17, p. 8500, doi. 10.7150/thno.60349
- By:
- Publication type:
- Article
Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor.
- Published in:
- PLoS ONE, 2021, v. 16, n. 8, p. 1, doi. 10.1371/journal.pone.0254125
- By:
- Publication type:
- Article
Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 689, doi. 10.1007/s00280-021-04239-9
- By:
- Publication type:
- Article
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 187, doi. 10.1016/j.cllc.2021.01.001
- By:
- Publication type:
- Article
Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis.
- Published in:
- Theranostics, 2021, v. 11, n. 8, p. 3964, doi. 10.7150/thno.54824
- By:
- Publication type:
- Article
Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 2, p. 664, doi. 10.1111/cts.12928
- By:
- Publication type:
- Article
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
An update on the immune landscape in lung and head and neck cancers.
- Published in:
- CA: A Cancer Journal for Clinicians, 2020, v. 70, n. 6, p. 505, doi. 10.3322/caac.21630
- By:
- Publication type:
- Article
Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7511, doi. 10.1002/cam4.3416
- By:
- Publication type:
- Article
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. e1586, doi. 10.1634/theoncologist.2020-0442
- By:
- Publication type:
- Article
MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor-mutant lung cancers.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.01000
- By:
- Publication type:
- Article
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589).
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 9, p. 2024, doi. 10.1002/cncr.32744
- By:
- Publication type:
- Article
Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups.
- Published in:
- Head & Neck, 2020, v. 42, n. 4, p. 678, doi. 10.1002/hed.26042
- By:
- Publication type:
- Article
Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 4, p. 882, doi. 10.1002/1878-0261.12645
- By:
- Publication type:
- Article
ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1198, doi. 10.1007/s10637-019-00736-0
- By:
- Publication type:
- Article
Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.
- Published in:
- Head & Neck, 2019, v. 41, n. 5, p. 1490, doi. 10.1002/hed.25379
- By:
- Publication type:
- Article
The clinical conundrum of managing relapsed small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models.
- Published in:
- PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0206309
- By:
- Publication type:
- Article
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Race-, Age-, and Gender-Based Characteristics and Toxicities of Targeted Therapies on Phase I Trials.
- Published in:
- Oncology, 2018, v. 95, n. 3, p. 138, doi. 10.1159/000488763
- By:
- Publication type:
- Article
Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
- Published in:
- Cancer Cytopathology, 2018, v. 126, n. 4, p. 236, doi. 10.1002/cncy.21969
- By:
- Publication type:
- Article
Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.
- Published in:
- PLoS ONE, 2017, v. 12, n. 9, p. 1, doi. 10.1371/journal.pone.0184254
- By:
- Publication type:
- Article
Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3476, doi. 10.1002/cncr.30763
- By:
- Publication type:
- Article
Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pulmonary Sarcomatoid Carcinoma: of the National Cancer Data An Analysis Base.
- Published in:
- Clinical Lung Cancer, 2017, v. 18, n. 3, p. 286, doi. 10.1016/j.cllc.2016.11.016
- By:
- Publication type:
- Article
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 10, p. 1163, doi. 10.1634/theoncologist.2016-0220
- By:
- Publication type:
- Article
Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article